Blend Therapeutics secures $16M from New Enterprise Associates, others – Washington Business Journal
Blend Therapeutics, a 1-year-old pre-clinical biotech focused on oncology drugs, has raised…
Super UserDecember 19, 2012
NHLBI Funding and Research Opportunities The following funding opportunities from the NHLBI…
Super UserDecember 18, 2012
University of Maryland System’s Diverse Space Offerings Provide Sterilization Technology Company the…
Super UserDecember 18, 2012
CONGRATULATIONS to 20 INNoVATE 2012 graduates—celebrating completion of their unique commercialization training…
Super UserDecember 18, 2012
University of Maryland, Baltimore said Monday it reached its $650 million fundraising…
Super UserDecember 17, 2012
Two little-hyped drugs developed by Human Genome Sciences Inc. and Sucampo Inc.…
Super UserDecember 17, 2012
Dr. Gene Green, a senior executive within Johns Hopkins Medicine's doctors group,…
Super UserDecember 17, 2012
Two Baltimore-area startups have received a total of $300,000 from InvestMaryland. Plasmonix…
Super UserDecember 13, 2012